Asston Pharmaceuticals Ltd — Important, 02-07-2026: Company Update

Asston Pharmaceuticals has announced a board meeting where its Board approved a preferential issue of up to 24.10 lakh equity shares. Each share, with a face value of ₹10, will be issued at ₹115, including a ₹105 premium, raising up to ₹27.72 crore. This allotment targets non-promoter investors for cash and aims to bolster the company's financials. The proposed issue requires shareholder approval, for which an Extraordinary General Meeting will convene.